Rogers

Rogers

Yahoo Finance • yesterday

Rogers (ROG) Stock Looks Overvalued After Its 73% Rise

Rogers has delivered a sharp move over the past year, which puts today's valuation squarely in focus. With the share price well above where it started the period, the question now is how much of that climb is supported by the company's ear... Full story

Yahoo Finance • 3 days ago

Positive interim data shows Roche’s sefaxersen significantly reduces proteinuria in people with IgA nephropathy (IgAN)

F. Hoffmann-La Roche Ltd In the phase III IMAgINATION study, sefaxersen demonstrated statistically significant and clinically meaningful reductions in proteinuria versus placebo at 37 weeks, showing best-in-class potential Sefaxersen inhi... Full story

Yahoo Finance • 3 days ago

Change in Roche’s Board of Directors

F. Hoffmann-La Roche Ltd Roche announced today that the Board of Directors of Roche Holding Ltd has approved to propose Dr. Christophe Weber, former CEO of Takeda Pharmaceuticals, for election to the Board of Directors at Roche's Annual G... Full story

Yahoo Finance • 4 days ago

[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase II results for dual GLP-1/GIP receptor agonist enicepatide in people living with type 2 diabetes and overweight or obesity

F. Hoffmann-La Roche Ltd At the highest dose (24 mg), enicepatide achieved a mean HbA1c reduction of 2.65% at 48 weeks, highlighting its potential for best-in-disease glycemic control In patients with poor baseline glycemic control (HbA1c... Full story

Yahoo Finance • 5 days ago

European Commission approves Roche’s Susvimo® for the treatment of neovascular age-related macular degeneration (nAMD)

F. Hoffmann-La Roche Ltd By continuously delivering medicine into the eye through the Contivue refillable implant, Susvimo is the first and only continuous delivery treatment that offers an alternative to standard-of-care eye injections f... Full story

Yahoo Finance • 5 days ago

3 Low-Volatility Stocks We Find Risky

3 Low-Volatility Stocks We Find Risky Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. Finding the right balance between safety and... Full story

Yahoo Finance • 5 days ago

LG Display launches 24.5-inch 720Hz Gaming OLED Panel

SEOUL, South Korea, Sept. 20, 2026 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, announced today its launch of a 24.5-inch 720Hz Gaming OLED panel, leading the esports monitor market paradigm.LG Display... Full story

Yahoo Finance • 8 days ago

CHMP recommends EU approval of Roche’s Ocrevus for children and adolescents with relapsing multiple sclerosis

F. Hoffmann-La Roche Ltd Ocrevus addresses a critical need in paediatric neurology as the first high- efficacy anti-CD20 treatment option for people with MS as young as 10 years old In the Phase III OPERETTA 2 study, Ocrevus demonstrated... Full story

Yahoo Finance • 9 days ago

Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases

F. Hoffmann-La Roche Ltd The center will be a hub for Roche and Genentech, bringing together expertise in Cardiovascular, Renal and Metabolism, as well as for data science and AI specialists to drive innovation in drug discovery and devel... Full story

Yahoo Finance • 13 days ago

Roche’s collaborator MediLink announces phase III data for Tam-Peli showing significantly improved overall survival in Chinese patient population with relapsed small-cell lung cancer

F. Hoffmann-La Roche Ltd Tambotatug pelitecan (Tam-Peli) demonstrated statistically significant efficacy over topotecan in a phase III study conducted in China, reducing the risk of death by 54% and disease progression by 71%, while achie... Full story

Yahoo Finance • 15 days ago

3 Profitable Stocks We Keep Off Our Radar

3 Profitable Stocks We Keep Off Our Radar Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn't mean it will thrive tomorrow. Prof... Full story

Yahoo Finance • 16 days ago

U.S. FDA grants Priority Review for Roche’s Enspryng for MOGAD, an autoimmune disease with no approved treatments

F. Hoffmann-La Roche Ltd If approved, Enspryng would be the first and only disease-modifying therapy for MOGAD (myelin oligodendrocyte glycoprotein antibody-associated disease) Filing acceptance is based on the Phase III METEOROID study s... Full story

Yahoo Finance • 24 days ago

Q2 Rundown: CTS (NYSE:CTS) Vs Other Electronic Components & Manufacturing Stocks

Q2 Rundown: CTS (NYSE:CTS) Vs Other Electronic Components & Manufacturing Stocks The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let's take a... Full story

Yahoo Finance • 29 days ago

Roche’s Vabysmo demonstrates sustained two-year results in a difficult-to-treat form of neovascular age-related macular degeneration (nAMD)

F. Hoffmann-La Roche Ltd The SALWEEN study showed significant improvements in vision and retinal health1 More than 60% of Asian patients with polypoidal choroidal vasculopathy (PCV), an aggressive subtype of nAMD, treated with Vabysmo sho... Full story

Yahoo Finance • last month

Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA

The PATHWAY HER2 (4B5) test and VENTANA HER2 Dual ISH DNA Probe Cocktail help identify HER2-positive metastatic gastric, gastroesophageal junction and esophageal adenocarcinoma. Differential diagnosis of these cancers, often aggressive and... Full story

Yahoo Finance • last month

ASUS Republic of Gamers Announces ROG XBOX Ally X20 is Now Available for Pre-Order in Canada

ASUS Computer International Available standalone or bundled with premium accessories, the ROG XBOX Ally X20 will be on shelves on October 15 KEY POINTS Buy the ROG XBOX Ally X20 standalone: The perfect choice for gamers who just want th... Full story

Yahoo Finance • last month

Starboard adds Dynatrace, Flowserve, and exits Beckton Dickson, among top Q2 trades

takasuu/iStock via Getty Images Starboard Value added Dynatrace (DT [https://seekingalpha.com/symbol/DT]) and Flowserve (FLS [https://seekingalpha.com/symbol/FLS]), while the fund exited Beckton Dickinson (BDX [https://seekingalpha.com/sy... Full story

Yahoo Finance • 2 months ago

ASUS Kicks Off Back-to-School Deals with Savings of Up to 40% on Student-Favorite Laptops and PCs!

ASUS Computer International Whether tackling coursework, creating content, gaming, or unwinding with entertainment after class, students can find the perfect ASUS device to power their success. Fremont, CA, Aug. 06, 2026 (GLOBE NEWSWIRE)... Full story

Yahoo Finance • 2 months ago

Roche expands cyclospora testing portfolio to support U.S. public health response

Roche has launched two new, real-time PCR tests to detect cyclospora, a diarrhea-causing infection, to help meet diverse needs of laboratories. The new tests expand the Roche cyclospora portfolio, providing laboratories with more flexible... Full story

Yahoo Finance • 2 months ago

Prediction: This International ETF Will Beat U.S. Stocks for the Next 5 Years

Buying international stocks hasn't always been a top priority for American investors. Some believe that Americans don't need to own international stocks because U.S. companies make so much of their revenue from foreign markets. And for mos... Full story